Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Minerva neurosciences - The Untold Story

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding to support development of roluperidone for schizophrenia.

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Monday's Intraday Session

Minerva Neurosciences up More Than 100% This Week, but Is It a Better Pick Than Vertex Pharma?

Minerva Neurosciences (NERV) and Vertex Pharmaceuticals (VRTX) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the industry. Since NERV has gained more than 100% this week, is it a better investment than VRTX? Read more to find out….

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

12 Health Care Stocks Moving In Monday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

Recap: Minerva Neurosciences Q1 Earnings

Recap: Minerva Neurosciences Q1 Earnings

Minerva Neurosciences (NASDAQ:NERV) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Minerva Neurosciences: Q4 Earnings Insights

Minerva Neurosciences: Q4 Earnings Insights

Minerva Neurosciences (NASDAQ:NERV) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

1

Organisations

Activision Blizzard

Palo Alto Networks

Rigetti Computing

TakeTwo Interactive

HC Wainwright & Co

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

380,561 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play